🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the ocular comfort and safety of olo...
Status
Completed
Location
Multiple Locations
Start Date
2011-04
Trial ID
NCT01326858
Rationale and Aims: Infection by dengue virus (DENV) causes major morbidity...
Status
Unknown
Location
National University Hospital (Investigational Medicine Unit)
Start Date
2015-03
Trial ID
NCT02673840
The purpose of this study was to evaluate the efficacy and safety of ketoti...
Status
Unknown
Location
Multiple Locations
Start Date
2022-09-01
Trial ID
NCT05511831
Treatments Being Tested
The aim of this study is to investigate the safety and efficacy of using ke...
Status
Completed
Location
Tanta Unuversity
Start Date
2023-05-20
Trial ID
NCT05616442
This is a Phase 2, multi-center, randomized, double-blind, placebo-controll...
Status
Recruiting
Location
The Center for Vulvovaginal Disorders - Washington, DC
Start Date
2026-01-02
Trial ID
NCT07257029
Treatments Being Tested
This study will evaluate the safety and efficacy of a new allergy medicatio...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00375596
Treatments Being Tested
PrEvention of posttraumatic contractuRes with Ketotifen 2 (PERK 2) is a Pha...
Status
Completed
Location
University of Maryland Medical Centre
Start Date
2019-04-26
Trial ID
NCT03582176
Treatments Being Tested
The purpose of this study is to evaluate the safety of a novel contact lens...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00569777
Treatments Being Tested
To evaluate the efficacy of Combo compared to its individual components and...
Status
Completed
Location
104 Butchertown Clinical Trials
Start Date
2022-11-18
Trial ID
NCT05591755
This is a phase 2 study that will consist of 4 visits over a 5 week period....
Status
Completed
Location
Ora
Start Date
2009-02
Trial ID
NCT00836485
Treatments Being Tested